Abu Dhabi: Burjeel Medical City, the flagship facility of Burjeel Holdings, has introduced a cutting-edge Epilepsy Monitoring Unit (EMU) within its Neuroscience Institute, aiming to enhance specialized care for those affected by epilepsy. This unit is among the few dedicated facilities in the UAE, marking a significant advancement in epilepsy diagnosis and management across the nation.

According to Emirates News Agency, the launch was attended by Dr. Mujtaba Ali Khan, CEO of Burjeel Medical City, and Dr. Mohammad Fityan, Chief Medical Officer of the facility. "Epilepsy affects millions of people worldwide, with profound impacts on patients and their families. The launch of our Epilepsy Monitoring Unit is a significant step towards delivering high-quality, patient-centered care. We have established the unit with a vision to serve those in need with compassion, expertise, and cutting-edge technology," stated John Sunil, Group CEO of Burjeel Holdings.

The EMU is designed to accommodate both adult and pediatric patients, featuring an advanced video EEG (vEEG) monitoring system. This system integrates electroencephalography to measure brain electrical activity with continuous video recording to observe patient behavior during seizures. This technology is crucial for understanding seizure activity, confirming epilepsy types, and ruling out conditions that mimic epilepsy. It facilitates accurate diagnosis and enables clinicians to assess whether patients with uncontrolled seizures might benefit from surgical intervention.

The establishment of the EMU is a pivotal step in bridging the treatment gap for epilepsy patients in the UAE, providing timely and expert care within the region.